Skip to content

Psilocybin research published in 2012

24 studies whose primary subject is psilocybin were published in 2012, up from 11 in 2011. Newest first. Back to the psilocybin overview

Studies

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin

Journal for the Scientific Study of Religion December 1, 2012 Katherine A Maclean, Jeannie‐marie Leoutsakos, Matthew W. Johnson et al. 412 citations

A large body of historical evidence describes the use of hallucinogenic compounds, such as psilocybin mushrooms, for religious purposes. But few scientific studies have attempted to measure or characterize hallucinogen‐occasioned spiritual experiences. The present study examined the factor structure of the Mystical Experience Questionnaire (MEQ), a self‐report measure that has been used to...

Swiss Psilocybin and US Dollars

November 7, 2012 Nicolas Langlitz

Abstract Chapter 2, “Swiss Psilocybin and US Dollars,” turns to the situation in Switzerland where proto-countercultural experiments in living have blossomed since the beginning of the twentieth century without ever leading to the kind of aggressive confrontations that the United States experienced in the 1960s. The government official overseeing the comeback of hallucinogen research in this...

Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner

Journal of Psychoactive Drugs November 1, 2012 Michael Lyvers, Molly Meester 97 citations

Psychedelic drugs have long been known to be capable of inducing mystical or transcendental experiences. However, given the common "recreational" nature of much present-day psychedelic use, with typical doses tending to be lower than those commonly taken in the 1960s, the extent to which illicit use of psychedelics today is associated with mystical experiences is not known. Furthermore the mild...

"Magic" mushrooms don't cause renal failure

BMJ October 17, 2012 Edward G. D. Tuddenham

“We have had recent experience with renal toxicity caused by deliberate ingestion of psilocybin mushrooms, which are eaten for their hallucinogenic effects. Acute renal failure secondary to the recreational use of mushrooms is rarely reported.”1 Each of these statements is problematic. The authors give no …

DOI: 10.1136/bmj.e6893 (opens in new tab) Psilocybin Hallucinogen Magic telescope Recreational drug +5

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Schizophrenia Bulletin October 6, 2012 Robin Carhart-Harris, Robert Leech, David Erritzøe et al. 267 citations

Psilocybin is a classic psychedelic and a candidate drug model of psychosis. This study measured the effects of psilocybin on resting-state network and thalamocortical functional connectivity (FC) using functional magnetic resonance imaging (fMRI). Fifteen healthy volunteers received intravenous infusions of psilocybin and placebo in 2 task-free resting-state scans. Primary analyses focused on...

Animal Models of Serotonergic Psychedelics

ACS Chemical Neuroscience September 24, 2012 James B. Hanks, Javier González-Maeso 152 citations

The serotonin 5-HT(2A) receptor is the major target of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Serotonergic psychedelics induce profound effects on cognition, emotion, and sensory processing that often seem uniquely human. This raises questions about the validity of animal models of psychedelic drug action. Nonetheless, recent findings suggest...

Hallucinogenic Drugs

Encyclopedia of Life Sciences August 15, 2012 Katherine R. Bonson 5 citations

Abstract Hallucinogens constitute one of the oldest classes of drugs used by humanity, often in the context of spiritual practices. Classic hallucinogens such as lysergic acid diethylamide (LSD), psilocybin, N,N ‐dimethyltryptamine (DMT), mescaline and 2,5‐dimethoxy‐4‐methylamphetamine (DOM) produce complex psychological and physical effects, including perceptual changes, cognitive shifts in...

Magic truffles or Philosopher's stones: a legal way to sell psilocybin?

Drug Testing and Analysis August 9, 2012 Manuela Pellegrini, Maria Concetta Rotolo, Emilia Marchei et al. 21 citations

“Magic mushrooms” is the most common name given to hallucinogenic fungi containing the psychoactive alkaloids psilocybin and psilocin. In recent years, fungis' sclerotia, commonly called “magic truffles” have become a form of supply of psychoactive Psilocybe alkaloids since Psilocybe sclerotia are not specifically included in the laws banning the sale, the purchase and the use of such...

DOI: 10.1002/dta.1400 (opens in new tab) Psilocybin Chromatography Selected reaction monitoring Solid phase extraction +3

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

Psychopharmacology July 26, 2012 André Schmidt, Michael Kometer, Rosilla Bachmann et al. 94 citations

RationaleBoth glutamate and serotonin (5-HT) play a key role in the pathophysiology of emotional biases. Recent studies indicate that the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine and the 5-HT receptor agonist psilocybin are implicated in emotion processing. However, as yet, no study has systematically compared their contribution to emotional biases.ObjectivesThis study...

A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens

NeuroQuantology June 1, 2012 Ümit Sayın 17 citations

Altered states of consciousness induced by hallucinogens (H-ASC) is still a vaguely understood phenomenon. Taken the diverse psychological effects they exert, the main mechanism of action of hallucinogens; LSD, ibogaine, THC, PCP, MDMA, methamphetamine, mescaline, psilocybin and DMT, of which psychological effects are discussed in the article, are not properly understood and explained by the...

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

Drug and Alcohol Dependence June 1, 2012 Matthew W Johnson, R Andrew Sewell, Roland R. Griffiths 121 citations

Psilocybin is a well-characterized classic hallucinogen (psychedelic) with a long history of religious use by indigenous cultures, and nonmedical use in modern societies. Although psilocybin is structurally related to migraine medications, and case studies suggest that psilocybin may be efficacious in treatment of cluster headache, little is known about the relationship between psilocybin and...

DOI: 10.1016/j.drugalcdep.2011.10.029 (opens in new tab) Full text (opens in new tab) Psilocybin Temporary side effect Common effect Dose-dependent effect +8

Substance use initiation: The role of simultaneous polysubstance use

Drug and Alcohol Review May 21, 2012 Janine V. Olthuis, Christine Darredeau, Sean P. Barrett 79 citations

Abstract Introduction and Aims. Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about its role in substance use initiation. Design and Methods. In the present study, 226 cannabis users completed structured interviews about their substance use history. For each substance ever used, participants provided details of their age of first use, their use in the...

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

Biological Psychiatry May 9, 2012 Michael Kometer, André Schmidt, Rosilla Bachmann et al. 300 citations

BackgroundSerotonin (5-HT) 1A and 2A receptors have been associated with dysfunctional emotional processing biases in mood disorders. These receptors further predominantly mediate the subjective and behavioral effects of psilocybin and might be important for its recently suggested antidepressive effects. However, the effect of psilocybin on emotional processing biases and the specific...

Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology

The FASEB Journal April 1, 2012 Evan J. Kyzar, Christopher Collins, Jeremy Green et al. 1 citation

Mescaline, phencyclidine (PCP) and psilocybin are potent hallucinogenic drugs strongly affecting both human and animal behavior. However, these compounds have not been previously investigated in zebrafish (Danio rerio), rapidly gaining popularity as a model in psychopharmacology research. Here, we examine the effects of mescaline, PCP and psilocybin in multiple behavioral paradigms. Mescaline...

Prediction of Psilocybin Response in Healthy Volunteers

PLoS One February 17, 2012 Erich Studerus, Alex Gamma, Michael Kometer et al. 372 citations

Responses to hallucinogenic drugs, such as psilocybin, are believed to be critically dependent on the user's personality, current mood state, drug pre-experiences, expectancies, and social and environmental variables. However, little is known about the order of importance of these variables and their effect sizes in comparison to drug dose. Hence, this study investigated the effects of 24...

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin

The British Journal of Psychiatry January 27, 2012 Robin Carhart-Harris, Robert Leech, Tom A. Williams et al. 241 citations

Background Psilocybin is a classic psychedelic drug that has a history of use in psychotherapy. One of the rationales for its use was that it aids emotional insight by lowering psychological defences. Aims To test the hypothesis that psilocybin facilitates access to personal memories and emotions by comparing subjective and neural responses to positive autobiographical memories under psilocybin...

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Proceedings of the National Academy of Sciences January 23, 2012 Alessandro Colasanti, Robin J. Tyacke, Robert Leech et al. 1,191 citations

Psychedelic drugs have a long history of use in healing ceremonies, but despite renewed interest in their therapeutic potential, we continue to know very little about how they work in the brain. Here we used psilocybin, a classic psychedelic found in magic mushrooms, and a task-free functional MRI (fMRI) protocol designed to capture the transition from normal waking consciousness to the...